These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23180655)

  • 1. Genetic variants in the vitamin D pathway and breast cancer disease-free survival.
    Pande M; Thompson PA; Do KA; Sahin AA; Amos CI; Frazier ML; Bondy ML; Brewster AM
    Carcinogenesis; 2013 Mar; 34(3):587-94. PubMed ID: 23180655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Polymorphisms in Vitamin D Metabolism and Signaling Genes and Risk of Breast Cancer: A Nested Case-Control Study.
    Clendenen TV; Ge W; Koenig KL; Axelsson T; Liu M; Afanasyeva Y; Andersson A; Arslan AA; Chen Y; Hallmans G; Lenner P; Kirchhoff T; Lundin E; Shore RE; Sund M; Zeleniuch-Jacquotte A
    PLoS One; 2015; 10(10):e0140478. PubMed ID: 26488576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-Nucleotide Polymorphisms in Vitamin D-Related Genes May Modify Vitamin D-Breast Cancer Associations.
    O'Brien KM; Sandler DP; Kinyamu HK; Taylor JA; Weinberg CR
    Cancer Epidemiol Biomarkers Prev; 2017 Dec; 26(12):1761-1771. PubMed ID: 28830874
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic variants in the vitamin D pathway genes VDBP and RXRA modulate cutaneous melanoma disease-specific survival.
    Yin J; Liu H; Yi X; Wu W; Amos CI; Fang S; Lee JE; Han J; Wei Q
    Pigment Cell Melanoma Res; 2016 Mar; 29(2):176-85. PubMed ID: 26575331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms in vitamin D receptor VDR/RXRA influence the likelihood of colon adenoma recurrence.
    Egan JB; Thompson PA; Ashbeck EL; Conti DV; Duggan D; Hibler E; Jurutka PW; Leroy EC; Martínez ME; Mount D; Jacobs ET
    Cancer Res; 2010 Feb; 70(4):1496-504. PubMed ID: 20145122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between polymorphic variation in VDR and RXRA and circulating levels of vitamin D metabolites.
    Hibler EA; Jurutka PW; Egan JB; Hu C; LeRoy EC; Martinez ME; Thompson PA; Jacobs ET
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):438-41. PubMed ID: 20307661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Vitamin D Receptor and Vitamin D-Binding Protein Polymorphisms with Familial Breast Cancer Prognosis in a Mono-Institutional Cohort.
    Aristarco V; Johansson H; Gandini S; Macis D; Zanzottera C; Tolva G; Feroce I; Accornero C; Bonanni B; Guerrieri-Gonzaga A; Serrano D
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33917614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of SNPs and haplotypes in vitamin D pathway genes and renal cancer risk.
    Karami S; Brennan P; Rosenberg PS; Navratilova M; Mates D; Zaridze D; Janout V; Kollarova H; Bencko V; Matveev V; Szeszenia-Dabrowska N; Holcatova I; Yeager M; Chanock S; Menashe I; Rothman N; Chow WH; Boffetta P; Moore LE
    PLoS One; 2009 Sep; 4(9):e7013. PubMed ID: 19753122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of SNP-SNP Interactions Between RANKL, OPG, CHI3L1, and VDR Genes With Breast Cancer Risk in Egyptian Women.
    Shaker OG; Senousy MA
    Clin Breast Cancer; 2019 Feb; 19(1):e220-e238. PubMed ID: 30309792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ENHO, RXRA, and LXRA polymorphisms and dyslipidaemia, related comorbidities and survival in haemodialysis patients.
    Grzegorzewska AE; Niepolski L; Świderska MK; Mostowska A; Stolarek I; Warchoł W; Figlerowicz M; Jagodziński PP
    BMC Med Genet; 2018 Nov; 19(1):194. PubMed ID: 30413149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between germline single nucleotide polymorphisms in the PI3K-AKT-mTOR pathway, obesity, and breast cancer disease-free survival.
    Pande M; Bondy ML; Do KA; Sahin AA; Ying J; Mills GB; Thompson PA; Brewster AM
    Breast Cancer Res Treat; 2014 Sep; 147(2):381-7. PubMed ID: 25108739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between SNPs and prognosis of breast cancer and pathogenic mechanism.
    He Y; Liu H; Chen Q; Shao Y; Luo S
    Mol Genet Genomic Med; 2019 Sep; 7(9):e871. PubMed ID: 31317673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphic variants in vitamin D signaling pathway genes and the risk of endometriosis-associated infertility.
    Szczepańska M; Mostowska A; Wirstlein P; Skrzypczak J; Misztal M; Jagodziński PP
    Mol Med Rep; 2015 Nov; 12(5):7109-15. PubMed ID: 26398313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single nucleotide polymorphisms of vitamin D binding protein, vitamin D receptor and retinoid X receptor alpha genes and response to hepatitis B vaccination in renal replacement therapy patients.
    Grzegorzewska AE; Jodłowska E; Mostowska A; Sowińska A; Jagodziński PP
    Expert Rev Vaccines; 2014 Nov; 13(11):1395-403. PubMed ID: 25245883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of the urokinase-type plasminogen activator, and its inhibitors and receptor in breast cancer patients.
    Borstnar S; Vrhovec I; Svetic B; Cufer T
    Clin Breast Cancer; 2002 Jun; 3(2):138-46. PubMed ID: 12123538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S4646 polymorphism in CYP19A1 gene is associated with the efficacy of hormone therapy in early breast cancer.
    Shao X; Cai J; Zheng Y; Wang J; Feng J; Huang Y; Shi L; Chen Z; Guo Y; Wang X
    Int J Clin Exp Pathol; 2015; 8(5):5309-17. PubMed ID: 26191232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer.
    Kuo SH; Yang SY; You SL; Lien HC; Lin CH; Lin PH; Huang CS
    Oncotarget; 2017 Mar; 8(13):20925-20938. PubMed ID: 28178648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups.
    van den Broek AJ; Broeks A; Horlings HM; Canisius SV; Braaf LM; Langerød A; Van't Veer LJ; Schmidt MK
    Breast Cancer Res Treat; 2011 Nov; 130(2):599-608. PubMed ID: 21667122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy.
    Kim HJ; Im SA; Keam B; Ham HS; Lee KH; Kim TY; Kim YJ; Oh DY; Kim JH; Han W; Jang IJ; Kim TY; Park IA; Noh DY
    Cancer Sci; 2015 Jan; 106(1):86-93. PubMed ID: 25410489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vitamin A and D receptor gene polymorphisms/haplotypes on immune responses to measles vaccine.
    Ovsyannikova IG; Haralambieva IH; Vierkant RA; O'Byrne MM; Jacobson RM; Poland GA
    Pharmacogenet Genomics; 2012 Jan; 22(1):20-31. PubMed ID: 22082653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.